SignatureFD’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.61K Hold
1,310
﹤0.01% 2742
2026
Q1
$9.5K Buy
1,310
+1,000
+323% +$13K ﹤0.01% 2542
2025
Q4
$5.27K Hold
310
﹤0.01% 2670
2025
Q3
$2.27K Hold
310
﹤0.01% 2917
2025
Q2
$2.02K Buy
+310
New +$2.05K ﹤0.01% 2863
2023
Q2
Sell
-238
Closed -$1.03K 3380
2023
Q1
$1.03K Buy
238
+138
+138% +$632 ﹤0.01% 2987
2022
Q4
$700 Buy
+100
New +$461 ﹤0.01% 3051
2021
Q4
Sell
-293
Closed -$1K 3294
2021
Q3
$1K Sell
293
-182
-38% -$1.1K ﹤0.01% 2950
2021
Q2
$3K Buy
475
+186
+64% +$1.22K ﹤0.01% 2500
2021
Q1
$2K Buy
289
+227
+366% +$2.18K ﹤0.01% 2544
2020
Q4
$0 Buy
+62
New +$520 ﹤0.01% 2725

Other funds holding WVE

SignatureFD's WVE Position: Q2 2026 in Review

SignatureFD held its Wave Life Sciences (WVE) position steady in Q2 2026 at 1,310 shares worth $7.61K. The position accounts for ﹤0.01% of the portfolio, ranked #2742.

SignatureFD first reported a position in WVE in Q4 2020 and has held it in 11 quarters since. The position peaked at $9.5K in Q1 2026. 28 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • SignatureFD held 1,310 shares of Wave Life Sciences worth $7.61K as of Q2 2026.
  • SignatureFD left its Wave Life Sciences share count unchanged in Q2 2026.
  • Wave Life Sciences made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2742 holding.
  • SignatureFD first reported a position in Wave Life Sciences in Q4 2020 and has held it in 11 quarters since.
  • SignatureFD's Wave Life Sciences position peaked at $9.5K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.